The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Fluorine in medicinal chemistry
Abstract
It has become evident that fluorinated compounds have a remarkable record in medicinal chemistry and will play a continuing role in providing lead compounds for therapeutic applications. This tutorial review provides a sampling of renowned fluorinated drugs and their mode of action with a discussion clarifying the role and impact of fluorine substitution on drug potency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Understanding organofluorine chemistry. An introduction to the C–F bond
O'Hagan, D. (2008) · Chem. Soc. Rev. · doi:10.1039/b711844a · Cited by 4,045
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
Fluorine in Medicinal Chemistry
Böhm, H., Banner, D., Bendels, S., Kansy, M., Kuhn, B., Müller, K., Obst‐Sander, U., & Stahl, M. (2004) · ChemBioChem · doi:10.1002/cbic.200301023 · Cited by 1,572
Fluorine substituent effects (on bioactivity)
Smart, B. E. (2001) · Journal of Fluorine Chemistry · doi:10.1016/s0022-1139(01)00375-x · Cited by 1,497
Chambers, R. D. (2004) · Wiley eBooks · doi:10.1002/9781444305371 · Cited by 1,085
Kim, D., Wang, L., Beconi, M., Eiermann, G. J., Fisher, M. H., He, H., Hickey, G. J., Kowalchick, J. E., Leiting, B., Lyons, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493156 · Cited by 822
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647
A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups
Kalgutkar, A., Gardner, I., Obach, R., Shaffer, C., Callegari, E., Henne, K., Mutlib, A., Dalvie, D., Lee, J., Nakai, Y., et al. (2005) · Current Drug Metabolism · doi:10.2174/1389200054021799 · Cited by 616
Metabolism of Fluorine-Containing Drugs
Park, B. K., Kitteringham, N. R., & O'Neill, P. M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.443 · Cited by 610
Barker, A. J., Gibson, K. H., Grundy, W., Godfrey, A. A., Barlow, J. J., Healy, M. P., Woodburn, J. R., Ashton, S. E., Curry, B. J., Scarlett, L., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00344-4 · Cited by 569
Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities
Morgenthaler, M., Schweizer, E., Hoffmann‐Röder, A., Benini, F., Martin, R. E., Jaeschke, G., Wagner, B., Fischer, H., Bendels, S., Zimmerli, D., et al. (2007) · ChemMedChem · doi:10.1002/cmdc.200700059 · Cited by 518
Orthogonal Multipolar Interactions in Structural Chemistry and Biology
Paulini, R., Müller, K., & Diederich, F. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462213 · Cited by 505
Andersson, M. I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg212 · Cited by 503
Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).
Prentis, R., Lis, Y., & Walker, Sr. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03318.x · Cited by 471
Rosenblum, S. B., Huynh, T., Afonso, A., Davis, H. R., Yumibe, N., Clader, J. W., & Burnett, D. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970701f · Cited by 361
Kauppi, B., Jakob, C., Färnegårdh, M., Yang, J., Ahola, H., Alarcon, M., Calles, K., Engström, O., Harlan, J., Muchmore, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212711200 · Cited by 336
THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
Roffey, S. J., Cole, S., Comby, P., Gibson, D., Jezequel, S. G., Nedderman, A. N. R., Smith, D. A., Walker, D. K., & Wood, N. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.731 · Cited by 330
9α-FLUORO DERIVATIVES OF CORTISONE AND HYDROCORTISONE
Fried, J., & Sabo, E. F. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01634a101 · Cited by 323
The human pharmacology of fluticasone propionate
Harding, S. M. (1990) · Respiratory Medicine · doi:10.1016/s0954-6111(08)80004-2 · Cited by 313
Van Heek, M., France, C. F., Compton, D. S., Mcleod, R. L., Yumibe, N. P., Alton, K. B., Sybertz, E. J., & Davis, H. R. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36992-7 · Cited by 305
Handbook of Radiopharmaceuticals: Radiochemistry and Applications
(2002) · Wiley eBooks · doi:10.1002/0470846380 · Cited by 281
Eriksson, T., Bjöurkman, S., Roth, B., Fyge, Å., & Höuglund, P. (1995) · Chirality · doi:10.1002/chir.530070109 · Cited by 251
Hale, J. J., Mills, S. G., MacCoss, M., Finke, P. E., Cascieri, M. A., Sadowski, S., Ber, E., Chicchi, G. G., Kurtz, M., Metzger, J., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980299k · Cited by 207
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant
Bergström, M., Hargreaves, R. J., Burns, H. D., Goldberg, M. R., Sciberras, D., Reines, S. A., Petty, K. J., Ögren, M., Antoni, G., Långström, B., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.007 · Cited by 201
Phillipps, G. H. (1990) · Respiratory Medicine · doi:10.1016/s0954-6111(08)80003-0 · Cited by 197
Chemical stability of prostacyclin (PGI2) in aqueous solutions
Cho, M. J., & Allen, M. A. (1978) · Prostaglandins · doi:10.1016/0090-6980(78)90037-0 · Cited by 196
Fluorinated nucleosides: Synthesis and biological implication
Liu, P., Sharon, A., & Chu, C. K. (2008) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2008.06.007 · Cited by 183
Marquez, V. E., Ezzitouni, A., Russ, P., Siddiqui, M. A., Ford, Feldman, R. J., Mitsuya, H., George, C., & Barchi, J. J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973535+ · Cited by 162
Maltodextrin-based proniosomes
Blazek-Welsh, A. I., & Rhodes, D. G. (2001) · AAPS PharmSci · doi:10.1208/ps030101 · Cited by 161
Olsen, J., Banner, D. W., Seiler, P., Wagner, B., Tschopp, T. B., Obst-Sander, U., Kansy, M., Müller, K., & Diederich, F. (2004) · ChemBioChem · doi:10.1002/cbic.200300907 · Cited by 160
Cox, C. D., Coleman, P. J., Breslin, M. J., Whitman, D. B., Garbaccio, R. M., Fraley, M. E., Buser, C. A., Walsh, E. S., Hamilton, K., Schaber, M. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800386y · Cited by 160
Acquired QT interval prolongation and HERG: implications for drug discovery and development
Finlayson, K., Witchel, H. J., McCulloch, J., & Sharkey, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.019 · Cited by 147
Myers, A. G., Barbay, J. K., & Zhong, B. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010113y · Cited by 145
Vulpetti, A., Hommel, U., Landrum, G. A., Lewis, R. A., & Dalvit, C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja905207t · Cited by 128
The Prodrugs of 5-Fluorouracil
Malet‐Martino, M., Jolimaître, P., & Martino, R. (2002) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023354146 · Cited by 128
Barry, A. L., & Brown, S. D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1948 · Cited by 123
Lauble, H., Kennedy, M. C., Emptage, M. H., Beinert, H., & Stout, C. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13699 · Cited by 121
Nieschalk, J., Batsanov, A. S., O’Hagan, D., & Howard, J. A. K. (1996) · Tetrahedron · doi:10.1016/0040-4020(95)00890-k · Cited by 114
Rowley, M., Hallett, D. J., Goodacre, S. C., Moyes, C. R., Crawforth, J. M., Sparey, T. J., Patel, S. S., Marwood, R., Patel, S., Thomas, S., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0004998 · Cited by 114
Difluoroethylamines as an amide isostere in inhibitors of cathepsin K
Isabel, É., Mellon, C., Boyd, M. J., Chauret, N., Deschênes, D., Desmarais, S., Falgueyret, J., Gauthier, J. Y., Khougaz, K., Lau, C. K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.070 · Cited by 111
A new class of carbonic anhydrase inhibitor.
Maren, T. H., & Conroy, C. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74305-1 · Cited by 108
(R)- and (S)-3-Fluorothalidomides: Isosteric Analogues of Thalidomide
Takéuchi, Y., Shiragami, T., Kimura, K., Suzuki, E., & Shibata, N. (1999) · Organic Letters · doi:10.1021/ol9902172 · Cited by 104
Statistical Analysis of the Effects of Common Chemical Substituents on Ligand Potency
Hajduk, P. J., & Sauer, D. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070838y · Cited by 101
Bergman, A. J., Ebel, D. L., Liu, F., et al. (2007) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.560 · Cited by 95
DICKINSON, R. P., Bell, A., Hitchcock, C. A., Narayanaswami, S., Ray, S. J., Richardson, K., & Troke, P. F. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00363-0 · Cited by 85
Volonterio, A., Bellosta, S., Bravin, F. M., Bellucci, M. C., Bruche, L. A. C., Colombo, G., Malpezzi, L., Mazzini, S., Meille, S. V., Meli, M., et al. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200304881 · Cited by 80
Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors
Xu, J., Ok, H., Gonzalez, E. J., Colwell, L. F., Habulihaz, B., He, H., Leiting, B., Lyons, K. A., Marsilio, F., Patel, R. A., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.099 · Cited by 77
Interaction of glucocorticoid analogues with the human glucocorticoid receptor
Berger, T. S., Parandoosh, Z., Perry, B. W., & Stein, R. B. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90414-e · Cited by 76
Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials
Sweeney, M. E., & Johnson, R. R. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.3.441 · Cited by 72
Kenny, P. W. (1994) · Journal of the Chemical Society Perkin Transactions 2 · doi:10.1039/p29940000199 · Cited by 71
Thymidylate synthetase. Model studies of inhibition by 5-trifluoromethyl-2'-deoxyuridylic acid
Santi, D. V., & Sakai, T. T. (1971) · Biochemistry · doi:10.1021/bi00795a018 · Cited by 71
Hale, J. J., Mills, S. G., MacCoss, M., Shah, S. K., Qi, H., Mathre, D. J., Cascieri, M. A., Sadowski, S. J., Strader, C. D., MacIntyre, D. E., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950654w · Cited by 68
Pharmacokinetics and Metabolism in Drug Design
Smith, D. A., Waterbeemd, H. V. D., & Walker, D. K. (2006) · Methods and principles in medicinal chemistry · doi:10.1002/3527608222 · Cited by 62
Chauret, N., Guay, D., Li, C., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00349-9 · Cited by 60
Wu, Y., Davis, C. D., Dworetzky, S. I., Fitzpatrick, W., Harden, D., He, H., Knox, R. J., Newton, A. E., Philip, T., Polson, C. T., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034111v · Cited by 60
Kim, D., Kowalchick, J. E., Edmondson, S. D., Mastracchio, A., Xu, J., Eiermann, G. J., Leiting, B., Wu, J. K., Pryor, K. D., Patel, R. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.098 · Cited by 58
Effect of Fluorine Substitution on the Agonist Specificity of Norepinephrine
Cantacuzène, D., Kirk, K. L., McCulloh, D. H., et al. (1979) · Science · doi:10.1126/science.221978 · Cited by 50
Koshida, R., Cox, S., Harmenberg, J., Gilljam, G., & Wahrén, B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.12.2083 · Cited by 49
Earl, J., & Kirkpatrick, P. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1015 · Cited by 41
Barchi, J. J., Karki, R. G., Nicklaus, M. C., Siddiqui, M. A., George, C. F., Mikhailopulo, I. A., & Márquez, V. E. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800964g · Cited by 40
Medicinal Chemistry of Selective Neurokinin-1 Antagonists
Humphrey, J. M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451925 · Cited by 39
Ligand Structural Aspects of hERG Channel Blockade
Aronov, A. M. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785700061 · Cited by 38
THE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGS
Huskey, S.-E. W., Dean, B. J., Doss, G. A., Wang, Z., Hop, C. E. C. A., Anari, R., Finke, P. E., Robichaud, A. J., Zhang, M., Wang, B., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.2.246 · Cited by 38
4-Fluorosulfonylpiperidines: Selective 5-HT2A ligands for the treatment of insomnia
Fish, L. R., Gilligan, M. T., Humphries, A. C., Ivarsson, M., Ladduwahetty, T., Merchant, K. J., O'Connor, D. V., Patel, S. S., Philipps, E., Vargas, H. M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.104 · Cited by 37
Håkansson, K., & Liljas, A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00798-5 · Cited by 36
Novel CCR1 antagonists with improved metabolic stability
Brown, M. F., Avery, M., Brissette, W. H., Chang, J. H., Colizza, K., Conklyn, M. J., DiRico, A. P., Gladue, R. P., Kath, J. C., Krueger, S. S., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.022 · Cited by 34
Structure?Activity Relationships for Three Macrolide Antibiotics in Haemophilus influenzae
Mabe, S., Eller, J., & Champney, W. S. (2004) · Current Microbiology · doi:10.1007/s00284-004-4312-9 · Cited by 29
Kath, J. C., DiRico, A. P., Gladue, R. P., Martin, W. H., McElroy, E. B., Stock, I. A., Tylaska, L. A., & Zheng, D. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.020 · Cited by 25
Plosker, G. L., Perry, C. M., & Goa, K. L. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119040-00009 · Cited by 24
Weber, A. E., & Thornberry, N. A. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42007-3 · Cited by 17
Fera, M. T., Giannone, M., Pallio, S., Tortora, A., Blandino, G., & Carbone, M. L. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00315-0 · Cited by 16
Fluorinated Inhalation Anesthetics
Halpern, D. F. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1202-2_26 · Cited by 14
Research works printed but not linked: 15
- Roman, 2003, Eur. J. Pharmacol., 479, 53, 10.1016/j.ejphar.2003.08.056 · doi:10.1016/j.ejphar.2003.08.056
- Robertson, 2005, Eur. J. Cancer, 41, 346, 10.1016/j.ejca.2004.07.035 · doi:10.1016/j.ejca.2004.07.035
- Adkins, 1998, Drugs, 56, 1055, 10.2165/00003495-199856060-00014 · doi:10.2165/00003495-199856060-00014
- Rabel, 2001, AAPS PharmSci, 3, 1, 10.1208/ps030428 · doi:10.1208/ps030428
- Van Niel, 1999, J. Med. Chem., 42, 2087, 10.1021/jm981133m · doi:10.1021/jm981133m
- Jacobs, 1994, J. Med. Chem., 37, 1282, 10.1021/jm00035a008 · doi:10.1021/jm00035a008
- Massa, 2001, Bioorg. Med. Chem. Lett., 11, 1625, 10.1016/S0960-894X(01)00244-X · doi:10.1016/s0960-894x(01)00244-x
- Muller, 1986, J. Pharm. Sci., 75, 987, 10.1002/jps.2600751016 · doi:10.1002/jps.2600751016
- Bannai, 1983, Tetrahedron, 39, 3807, 10.1016/S0040-4020(01)88623-3 · doi:10.1016/s0040-4020(01)88623-3
- Chang, 1997, Prostaglandins, 53, 83, 10.1016/S0090-6980(97)00003-8 · doi:10.1016/s0090-6980(97)00003-8
- Barrett, 1998, J. Am. Chem. Soc., 120, 449, 10.1021/ja973210t · doi:10.1021/ja973210t
- Malet-Martino, 2002, Curr. Med. Chem.: Anti-Cancer Agents, 2, 267
- Barchi, Jr., 1997, J. Biochem. Biophys. Methods, 34, 11, 10.1016/S0165-022X(96)00032-2 · doi:10.1016/s0165-022x(96)00032-2
- Beuthien-Baumann, 2000, Carbohydr. Res., 327, 107, 10.1016/S0008-6215(00)00030-6 · doi:10.1016/s0008-6215(00)00030-6
- Cunningham, 2005, Drug Discovery Today: Technol., 2, 311, 10.1016/j.ddtec.2005.11.003 · doi:10.1016/j.ddtec.2005.11.003
Cited by
Prier, C. K., Rankic, D. A., & MacMillan, D. W. C. (2013) · Chemical Reviews · doi:10.1021/cr300503r · Cited by 9,590
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Visible light photoredox catalysis: applications in organic synthesis
Narayanam, J. M. R., & Stephenson, C. R. J. (2011) · Chem. Soc. Rev. · doi:10.1039/b913880n · Cited by 4,161
Applications of Fluorine in Medicinal Chemistry
Gillis, E. P., Eastman, K. J., Hill, M. D., Donnelly, D. J., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00258 · Cited by 3,618
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Metadata
- Authors
- Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V.
- Venue
- Chem. Soc. Rev.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2008
- Volume
- 37
- Issue
- 2
- Pages
- 320-330
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2116087305
- Cited by
- 7,570
- References
- 80
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.